Home » Topics » BioWorld Science

BioWorld Science
RSS

New USP30 inhibitors identified at Mission Therapeutics

Dec. 24, 2021

Janssen Pharmaceutica synthesizes new Mcl-1 inhibitors

Dec. 24, 2021

Trinuero, DGMIF identify SERT, NET and DAT inhibitors

Dec. 24, 2021

CSIPI and Shanghai Zhongze Therapeutics patent dopamine D2/D3/5-HT2A receptor antagonists

Dec. 24, 2021

Dual PI3K/BRD4 inhibitors divulged by Monash University, Peter MacCallum Cancer Centre

Dec. 24, 2021

Alphataxin increases CD4+ tumor-infiltrating T cells and suppresses renal cell cancer in mice

Dec. 24, 2021

Engineered AAV capsids allow specific transgene expression in the brain of mouse and marmoset

Dec. 24, 2021

British Pakistani genomics study illustrates need for diversity

Dec. 24, 2021

LogicBio nominates development candidate for treatment of hereditary tyrosinemia type 1

Dec. 23, 2021

Claritas to develop R-107 for persistent pulmonary hypertension of the newborn

Dec. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...